Introducing MiYOSMART iQ*
A new era in myopia control.
Every child is different, and so is their myopia progression. Backed by years of clinical research, MiYOSMART iQ builds on the proven foundation of D.I.M.S. Technology with Triple Enhanced Design (DIMS TED), developed to enable effective myopia control in children.
Myopia progression can be controlled, not only corrected.
MiYOSMART iQ uses D.I.M.S. Technology with a Triple Enhanced Design (DIMS TED).
intended to continuously activate the near-peripheral retina³⁻⁵
to enable a stronger myopic defocus signal
Expanding the coverage of the child's peripheral visual field with myopic defocus signal
intended to continuously activate the near-peripheral retina³⁻⁵
to enable a stronger myopic defocus signal
Expanding the coverage of the child's peripheral visual field with myopic defocus signal
MiYOSMART iQ spectacle lenses have been evaluated in a randomised controlled clinical trial in children aged 4 to 12 years old. These are the clinical results you can trust from D.I.M.S. Technology to date.1,2,6
Stop myopia progression,* on average, in the first 12 months of wear.¹˒²
MiYOSMART iQ spectacle lenses are the innovative solution for controlling myopia progression in an easy, safe, effective, and non-invasive way.¹˒²
MiYOSMART iQ is HOYA’s first spectacle lens with reported clinical evidence for effective control of myopia progression from the age of 4 years, as a monotherapy.*¹˒²˒⁷˒⁸
HOYA's new S.P.A.R.K. coating is a protective solution developed for MiYOSMART iQ spectacle lenses. Designed with children in mind and built to last, it is engineered to withstand frequent handling and everyday wear while keeping vision clear over time.
Children may find it inconvenient to change their spectacles every time they step outdoors. MiYOSMART iQ Chameleon spectacle lenses do it automatically for them.
Using the same D.I.M.S. Technology as MiYOSMART, they help control myopia and slow its progression, ¹˒²˒¹¹˒¹² and quickly adapt to the varying level of light, providing your child with as much protection as needed at any time and place.¹³
Bringing a few questions to your appointment can help you make the most of your visit and feel more confident when discussing your child's vision care with your Eye Care Professional.
*Disclaimer: MiYOSMART iQ and MiYOSMART have not been approved for myopia management in all countries, including the U.S., and are not currently available for sale in all countries, including the U.S.
MiYOSMART iQ and MiYOSMART spectacle lenses may not be able to address individuals’ conditions due to natural deficiencies, illness, pre-existing medical conditions and/or advanced age of consumers. The information contained herein is for general information and is not intended to constitute medical advice. Please consult your Eye Care Professional for more information prior to the use of MiYOSMART iQ and MiYOSMART spectacle lenses.
**Stop myopia progression on average defined as average Spherical Equivalent Refraction ≥0.00D. Outcomes for myopic children aged 4 to 12 years. They may vary per age group and other parameters at the start of MiYOSMART iQ treatment.
***Based on internal HOYA testing conducted in accordance with ISO 8980-3:2022. Results show that UV transmittance across 280–380 nm of 0.00%, for a center thickness of 2.0 mm ±0.2 mm.
References
